Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Seer, Inc. - Class A Common Stock (NQ:SEER)

2.080 +0.030 (+1.46%)
Streaming Delayed Price Updated: 11:53 AM EDT, Aug 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Seer, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
From Seer, Inc.
Via GlobeNewswire
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
From Seer, Inc.
Via GlobeNewswire
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
Combined Workflow of Proteograph™ XT Assay and Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer Robustly Identifies over 13,000 Protein Groups Across a Study of 2,840 Subjects 
From Seer, Inc.
Via GlobeNewswire
Recap: Seer Q4 Earnings
 
Via Benzinga
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
Why Shares of Seer Are Slumping Wednesday
The company reported a net loss but improved revenue in the second quarter. 
Via The Motley Fool
SEER Stock Earnings: Seer Meets EPS, Misses Revenue for Q1 2024
SEER stock results show that Seer met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Seer Reports First Quarter 2024 Financial Results
Demonstrated the power of the Proteograph Product Suite with a growing number of customer presentations and publications 
From Seer, Inc.
Via GlobeNewswire
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
From Seer, Inc.
Via GlobeNewswire
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
From Seer, Inc.
Via GlobeNewswire
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer data 
From Seer, Inc.
Via GlobeNewswire
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
From Seer, Inc.
Via GlobeNewswire
Zoom Video And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by around 1% on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
From Seer, Inc.
Via GlobeNewswire
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
From Seer, Inc.
Via GlobeNewswire
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
From Seer, Inc.
Via GlobeNewswire
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
From Seer, Inc.
Via GlobeNewswire
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
Seer technology receives recognition for excellence in the field of proteomics 
From Seer, Inc.
Via GlobeNewswire
Seer Reports Third Quarter 2023 Financial Results
Expanded access to the Proteograph™ Product Suite through the Seer Technology Access Center, new distributors and a new Center of Excellence 
From Seer, Inc.
Via GlobeNewswire
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
Panome Bio adds deep, unbiased proteomics to their proprietary metabolomics platform to deliver innovative multi-omics services 
From Seer, Inc.
Via GlobeNewswire
Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
From Seer, Inc.
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
7 Contrarian Stocks to Buy for the High-Stakes Gambler
With limited options available as the market rotates out of risk-on assets, speculators may try their luck with contrarian stocks to buy. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
Seer to Participate in Upcoming September Investor Conferences
From Seer, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 150 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 128 companies set new 52-week lows. 
Via Benzinga
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Seer Reports Second Quarter 2023 Financial Results
Launched Proteograph XT Assay Kit, enabling rapid proteomics and large-scale studies 
From Seer, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.